Companion Animal Specialty Drugs Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Germany, UK, China, Japan - Size and Forecast 2024-2028
| Published: Oct 2023 | Pages: 168 | SKU: IRTNTR44185 |
Companion Animal Specialty Drugs Market 2024-2028
The companion animal specialty drugs market size is estimated to grow by USD 4.55 billion accelerating at a CAGR of 6.68% between 2023 and 2028.
Key Findings:
- The companion animal specialty drugs market remained historically at high levels from 2018 to 2023.
- The market is segmented into Distribution Channel, Product, and Geography.
- Veterinary hospitals sub-segment under the Distribution Channel segment generated the largest revenue in 2018.
- Key regions boosting the market growth include North America, Europe, Asia, and Rest of World (ROW).
Companion animal specialty drugs market Share
For More Highlights About this Report, Download Free Sample in a Minute
Companion Animal Specialty Drugs Market: Key Drivers, Trends and Challenges
Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
Key Companion Animal Specialty Drugs Market Driver
One of the key factors driving the companion animal specialty drugs is the rise in the aging companion animal population. There is an increase in the elderly companion animal population across the world as the owners of companion animals wish to provide proper nutrition to control aging effects. As a result, it is fuelling the demand for health products for companion animals.
Moreover, the energy requirement of dogs minimizes with age because of metabolic rates. In addition, as the protein needs and fat utilization of companion animals change with age, the diet requirements vary as well. Furthermore, the requirement for minerals and vitamins to support of growing dogs is adequate for senior dogs. Hence, such factors are positively impacting the market. Therefore, it is expected to drive the market growth during the forecast period.
Key Companion Animal Specialty Drugs Market Trends
A key factor shaping the companion animal specialty drugs market growth is the rising obesity in companion animals. There is an increasing incidence of obesity among companion animals. One of the main factors resulting in the increasing obesity is unhealthy feeding habits. Several other factors also determine the weight of pets.
Moreover, one of the most critical among them is exercise. In addition, several veterinarians suggest that cats, especially indoor cats, must have at least forty minutes of playtime every day. For instance, the recommended playtime for adult dogs is about an hour. Therefore, the balance between meals and exercise holds the same importance in animals as they do in humans, which is positively impacting the market. Hence, such factors are expected to drive market growth during the forecast period.
Major Companion Animal Specialty Drugs Market Challenge
Patent expiry of companion animal specialty drugs is one of the key challenges hindering the growth of the companion animal specialty drugs market growth. Several companion animal specialty drugs are expected to lose their patents in the coming years. In addition, the decline in prices due to patent expiries will negatively impact the global companion animal specialty drugs market.
Moreover, the process of drug approval for veterinary use is far more stringent than the drugs intended for humans, resulting in lesser rates of drug approvals for animals. Therefore, it further aggravates concerns over the high rate of patent expiries described above. Hence, such factors are hindering the market growth during the forecast period.
Companion Animal Specialty Drugs Market Segmentations
The distribution channel segment is classified into veterinary hospitals, pet care clinics, and pharmacy stores. The product segment is classified into vaccines, antibiotics, parasiticides, feed additives, and others. The geography segment includes key regions such as North America, Europe, Asia, and the Rest of the World (ROW)
Distribution Channel Segment
The veterinary hospitals segment is estimated to witness significant growth during the forecast period. This segment offers a range of healthcare services for companion animals. Some of the key aspects of proper pet care include grooming, vaccination, and flea treatment. In addition, the facilities for diagnosis, prophylaxis, medical treatment, and surgery can be availed at veterinary hospitals.
Get a glance at the market contribution of various segments Download the PDF Sample
The veterinary hospitals segment was the largest segment and was valued at USD 5.10 billion in 2018. Moreover, animal healthcare companies increasingly focus on veterinary hospitals, as most of the prescriptions for companion animals are filled directly from veterinary hospitals. In addition, regular visits to veterinary hospitals are inexpensive and help in pet care, early diagnosis of illness, and periodic assessments of behavioral issues if required. Furthermore, regular visits to veterinary hospitals can identify risk factors at the initial stages. Hence, the high awareness regarding companion animals' health is fuelling the growth of this segment which in turn drives the market growth during the forecast period.
Regional Analysis
For more insights on the market share of various regions Download PDF Sample now!
North America is estimated to contribute 35% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
North America leads globally in pet ownership, with 66% of US households owning pets, according to the 2023-2024 National Pet Owners Survey by the American Pet Products Association. This marks an increase from 62% in 2022 and 56% in 1988. The region's market growth is driven by the widespread interest in pet ownership, especially in the US, Canada, and Mexico.
The rising adoption rate of pets, fueled by the desire for companionship, and the pet humanization trend, where pets are treated as family members, contribute to North America's position as the highest spender on premium and luxury pet care. In Canada, the demand for pet healthcare is rising, with owners seeking high-quality products to improve their pets' quality of life, leading to increased availability of specialty drugs. The growing consideration of pets as integral family members drives the demand for companion animal specialty drugs, fueling the regional market's growth during the forecast period.
Key Companies in Companion Animal Specialty Drugs Market
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
Bayer AG: The company focuses on companion animal specialty drugs through proteins that are contained in milk, eggs, and meat.
The research report also includes detailed analyses of the competitive landscape of the market and information about 15 market companies, including:
- Beaphar Beheer BV
- Bimeda Holdings Ltd.
- Boehringer Ingelheim International GmbH
- Ceva Sante Animale
- Chanelle Pharma Group
- Dechra Pharmaceuticals Plc
- Elanco Animal Health Inc.
- Kyoritsuseiyaku Corp.
- LABORATORIOS CALIER S.A
- Mars Inc.
- Merck and Co. Inc.
- Neogen Corp.
- Norbrook Laboratories Ltd.
- Tianjin ringpu bio-technology Co. Ltd.
- Vetoquinol SA
- Virbac Group
- Zenex Animal Health India Private Ltd.
- Zoetis Inc.
- Orion Corp.
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
|
Companion Animal Specialty Drugs Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
168 |
|
Base year |
2023 |
|
Historic period |
2018 - 2022 |
|
Forecast period |
2024-2028 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 6.68% |
|
Market growth 2024-2028 |
USD 4.55 billion |
|
Market structure |
Fragmented |
|
YoY growth 2023-2024(%) |
6.22 |
|
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
|
Performing market contribution |
North America at 35% |
|
Key countries |
US, Germany, UK, China, and Japan |
|
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
|
Key companies profiled |
Bayer AG, Beaphar Beheer BV, Bimeda Holdings Ltd., Boehringer Ingelheim International GmbH, Ceva Sante Animale, Chanelle Pharma Group, Dechra Pharmaceuticals Plc, Elanco Animal Health Inc., Kyoritsuseiyaku Corp., LABORATORIOS CALIER S.A, Mars Inc., Merck and Co. Inc., Neogen Corp., Norbrook Laboratories Ltd., Tianjin ringpu bio-technology Co. Ltd., Vetoquinol SA, Virbac Group, Zenex Animal Health India Private Ltd., Zoetis Inc., and Orion Corp. |
|
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period |
|
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
What are the Key Data Covered in this Companion Animal Specialty Drugs Market Research Report?
- CAGR of the market during the forecast period
- Detailed information on factors that will drive the growth of the market between 2024 and 2028
- Precise estimation of the size of the market size and its contribution of the market in focus to the parent market
- Accurate predictions about upcoming trends and changes in consumer behaviour
- Growth of the market industry across North America, Europe, Asia, and Rest of World (ROW)
- Thorough analysis of the market’s competitive landscape and detailed information about companies
- Comprehensive analysis of factors that will challenge the growth of market companies
We can help! Our analysts can customize this market research report to meet your requirements.
1 Executive Summary
- 1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Distribution Channel
- Exhibit 06: Executive Summary – Chart on Market Segmentation by Product
- Exhibit 07: Executive Summary – Chart on Incremental Growth
- Exhibit 08: Executive Summary – Data Table on Incremental Growth
- Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
2 Market Landscape
- 2.1 Market ecosystem
- Exhibit 10: Parent market
- Exhibit 11: Market Characteristics
3 Market Sizing
- 3.1 Market definition
- Exhibit 12: Offerings of vendors included in the market definition
- 3.2 Market segment analysis
- Exhibit 13: Market segments
- 3.3 Market size 2023
- 3.4 Market outlook: Forecast for 2023-2028
- Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
- Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
- Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
- 4.1 Global companion animal specialty drugs market 2018 - 2022
- Exhibit 18: Historic Market Size – Data Table on global companion animal specialty drugs market 2018 - 2022 ($ billion)
- 4.2 Distribution Channel Segment Analysis 2018 - 2022
- Exhibit 19: Historic Market Size – Distribution Channel Segment 2018 - 2022 ($ billion)
- 4.3 Product Segment Analysis 2018 - 2022
- Exhibit 20: Historic Market Size – Product Segment 2018 - 2022 ($ billion)
- 4.4 Geography Segment Analysis 2018 - 2022
- Exhibit 21: Historic Market Size – Geography Segment 2018 - 2022 ($ billion)
- 4.5 Country Segment Analysis 2018 - 2022
- Exhibit 22: Historic Market Size – Country Segment 2018 - 2022 ($ billion)
5 Five Forces Analysis
- 5.1 Five forces summary
- Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
- 5.2 Bargaining power of buyers
- Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
- 5.3 Bargaining power of suppliers
- Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
- 5.4 Threat of new entrants
- Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028
- 5.5 Threat of substitutes
- Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028
- 5.6 Threat of rivalry
- Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028
- 5.7 Market condition
- Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Distribution Channel
- 6.1 Market segments
- Exhibit 30: Chart on Distribution Channel - Market share 2023-2028 (%)
- Exhibit 31: Data Table on Distribution Channel - Market share 2023-2028 (%)
- 6.2 Comparison by Distribution Channel
- Exhibit 32: Chart on Comparison by Distribution Channel
- Exhibit 33: Data Table on Comparison by Distribution Channel
- 6.3 Veterinary hospitals - Market size and forecast 2023-2028
- Exhibit 34: Chart on Veterinary hospitals - Market size and forecast 2023-2028 ($ billion)
- Exhibit 35: Data Table on Veterinary hospitals - Market size and forecast 2023-2028 ($ billion)
- Exhibit 36: Chart on Veterinary hospitals - Year-over-year growth 2023-2028 (%)
- Exhibit 37: Data Table on Veterinary hospitals - Year-over-year growth 2023-2028 (%)
- 6.4 Pet care clinics - Market size and forecast 2023-2028
- Exhibit 38: Chart on Pet care clinics - Market size and forecast 2023-2028 ($ billion)
- Exhibit 39: Data Table on Pet care clinics - Market size and forecast 2023-2028 ($ billion)
- Exhibit 40: Chart on Pet care clinics - Year-over-year growth 2023-2028 (%)
- Exhibit 41: Data Table on Pet care clinics - Year-over-year growth 2023-2028 (%)
- 6.5 Pharmacy stores - Market size and forecast 2023-2028
- Exhibit 42: Chart on Pharmacy stores - Market size and forecast 2023-2028 ($ billion)
- Exhibit 43: Data Table on Pharmacy stores - Market size and forecast 2023-2028 ($ billion)
- Exhibit 44: Chart on Pharmacy stores - Year-over-year growth 2023-2028 (%)
- Exhibit 45: Data Table on Pharmacy stores - Year-over-year growth 2023-2028 (%)
- 6.6 Market opportunity by Distribution Channel
- Exhibit 46: Market opportunity by Distribution Channel ($ billion)
- Exhibit 47: Data Table on Market opportunity by Distribution Channel ($ billion)
7 Market Segmentation by Product
- 7.1 Market segments
- Exhibit 48: Chart on Product - Market share 2023-2028 (%)
- Exhibit 49: Data Table on Product - Market share 2023-2028 (%)
- 7.2 Comparison by Product
- Exhibit 50: Chart on Comparison by Product
- Exhibit 51: Data Table on Comparison by Product
- 7.3 Vaccines - Market size and forecast 2023-2028
- Exhibit 52: Chart on Vaccines - Market size and forecast 2023-2028 ($ billion)
- Exhibit 53: Data Table on Vaccines - Market size and forecast 2023-2028 ($ billion)
- Exhibit 54: Chart on Vaccines - Year-over-year growth 2023-2028 (%)
- Exhibit 55: Data Table on Vaccines - Year-over-year growth 2023-2028 (%)
- 7.4 Antibiotics - Market size and forecast 2023-2028
- Exhibit 56: Chart on Antibiotics - Market size and forecast 2023-2028 ($ billion)
- Exhibit 57: Data Table on Antibiotics - Market size and forecast 2023-2028 ($ billion)
- Exhibit 58: Chart on Antibiotics - Year-over-year growth 2023-2028 (%)
- Exhibit 59: Data Table on Antibiotics - Year-over-year growth 2023-2028 (%)
- 7.5 Parasiticides - Market size and forecast 2023-2028
- Exhibit 60: Chart on Parasiticides - Market size and forecast 2023-2028 ($ billion)
- Exhibit 61: Data Table on Parasiticides - Market size and forecast 2023-2028 ($ billion)
- Exhibit 62: Chart on Parasiticides - Year-over-year growth 2023-2028 (%)
- Exhibit 63: Data Table on Parasiticides - Year-over-year growth 2023-2028 (%)
- 7.6 Feed additives - Market size and forecast 2023-2028
- Exhibit 64: Chart on Feed additives - Market size and forecast 2023-2028 ($ billion)
- Exhibit 65: Data Table on Feed additives - Market size and forecast 2023-2028 ($ billion)
- Exhibit 66: Chart on Feed additives - Year-over-year growth 2023-2028 (%)
- Exhibit 67: Data Table on Feed additives - Year-over-year growth 2023-2028 (%)
- 7.7 Others - Market size and forecast 2023-2028
- Exhibit 68: Chart on Others - Market size and forecast 2023-2028 ($ billion)
- Exhibit 69: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
- Exhibit 70: Chart on Others - Year-over-year growth 2023-2028 (%)
- Exhibit 71: Data Table on Others - Year-over-year growth 2023-2028 (%)
- 7.8 Market opportunity by Product
- Exhibit 72: Market opportunity by Product ($ billion)
- Exhibit 73: Data Table on Market opportunity by Product ($ billion)
8 Customer Landscape
- 8.1 Customer landscape overview
- Exhibit 74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
- 9.1 Geographic segmentation
- Exhibit 75: Chart on Market share by geography 2023-2028 (%)
- Exhibit 76: Data Table on Market share by geography 2023-2028 (%)
- 9.2 Geographic comparison
- Exhibit 77: Chart on Geographic comparison
- Exhibit 78: Data Table on Geographic comparison
- 9.3 North America - Market size and forecast 2023-2028
- Exhibit 79: Chart on North America - Market size and forecast 2023-2028 ($ billion)
- Exhibit 80: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
- Exhibit 81: Chart on North America - Year-over-year growth 2023-2028 (%)
- Exhibit 82: Data Table on North America - Year-over-year growth 2023-2028 (%)
- 9.4 Europe - Market size and forecast 2023-2028
- Exhibit 83: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
- Exhibit 84: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
- Exhibit 85: Chart on Europe - Year-over-year growth 2023-2028 (%)
- Exhibit 86: Data Table on Europe - Year-over-year growth 2023-2028 (%)
- 9.5 Asia - Market size and forecast 2023-2028
- Exhibit 87: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
- Exhibit 88: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
- Exhibit 89: Chart on Asia - Year-over-year growth 2023-2028 (%)
- Exhibit 90: Data Table on Asia - Year-over-year growth 2023-2028 (%)
- 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Exhibit 91: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
- Exhibit 92: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
- Exhibit 93: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Exhibit 94: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- 9.7 US - Market size and forecast 2023-2028
- Exhibit 95: Chart on US - Market size and forecast 2023-2028 ($ billion)
- Exhibit 96: Data Table on US - Market size and forecast 2023-2028 ($ billion)
- Exhibit 97: Chart on US - Year-over-year growth 2023-2028 (%)
- Exhibit 98: Data Table on US - Year-over-year growth 2023-2028 (%)
- 9.8 Germany - Market size and forecast 2023-2028
- Exhibit 99: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
- Exhibit 100: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
- Exhibit 101: Chart on Germany - Year-over-year growth 2023-2028 (%)
- Exhibit 102: Data Table on Germany - Year-over-year growth 2023-2028 (%)
- 9.9 UK - Market size and forecast 2023-2028
- Exhibit 103: Chart on UK - Market size and forecast 2023-2028 ($ billion)
- Exhibit 104: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
- Exhibit 105: Chart on UK - Year-over-year growth 2023-2028 (%)
- Exhibit 106: Data Table on UK - Year-over-year growth 2023-2028 (%)
- 9.10 China - Market size and forecast 2023-2028
- Exhibit 107: Chart on China - Market size and forecast 2023-2028 ($ billion)
- Exhibit 108: Data Table on China - Market size and forecast 2023-2028 ($ billion)
- Exhibit 109: Chart on China - Year-over-year growth 2023-2028 (%)
- Exhibit 110: Data Table on China - Year-over-year growth 2023-2028 (%)
- 9.11 Japan - Market size and forecast 2023-2028
- Exhibit 111: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
- Exhibit 112: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
- Exhibit 113: Chart on Japan - Year-over-year growth 2023-2028 (%)
- Exhibit 114: Data Table on Japan - Year-over-year growth 2023-2028 (%)
- 9.12 Market opportunity by geography
- Exhibit 115: Market opportunity by geography ($ billion)
- Exhibit 116: Data Tables on Market opportunity by geography ($ billion)
10 Drivers, Challenges, and Trends
- 10.1 Market drivers
- 10.2 Market challenges
- 10.3 Impact of drivers and challenges
- Exhibit 117: Impact of drivers and challenges in 2023 and 2028
- 10.4 Market trends
11 Vendor Landscape
- 11.1 Overview
- 11.2 Vendor landscape
- Exhibit 118: Overview on Criticality of inputs and Factors of differentiation
- 11.3 Landscape disruption
- Exhibit 119: Overview on factors of disruption
- 11.4 Industry risks
- Exhibit 120: Impact of key risks on business
12 Vendor Analysis
- 12.1 Vendors covered
- Exhibit 121: Vendors covered
- 12.2 Market positioning of vendors
- Exhibit 122: Matrix on vendor position and classification
- 12.3 Bayer AG
- Exhibit 123: Bayer AG - Overview
- Exhibit 124: Bayer AG - Business segments
- Exhibit 125: Bayer AG - Key news
- Exhibit 126: Bayer AG - Key offerings
- Exhibit 127: Bayer AG - Segment focus
- 12.4 Beaphar Beheer BV
- Exhibit 128: Beaphar Beheer BV - Overview
- Exhibit 129: Beaphar Beheer BV - Product / Service
- Exhibit 130: Beaphar Beheer BV - Key offerings
- 12.5 Bimeda Holdings Ltd.
- Exhibit 131: Bimeda Holdings Ltd. - Overview
- Exhibit 132: Bimeda Holdings Ltd. - Product / Service
- Exhibit 133: Bimeda Holdings Ltd. - Key offerings
- 12.6 Boehringer Ingelheim International GmbH
- Exhibit 134: Boehringer Ingelheim International GmbH - Overview
- Exhibit 135: Boehringer Ingelheim International GmbH - Business segments
- Exhibit 136: Boehringer Ingelheim International GmbH - Key news
- Exhibit 137: Boehringer Ingelheim International GmbH - Key offerings
- Exhibit 138: Boehringer Ingelheim International GmbH - Segment focus
- 12.7 Ceva Sante Animale
- Exhibit 139: Ceva Sante Animale - Overview
- Exhibit 140: Ceva Sante Animale - Product / Service
- Exhibit 141: Ceva Sante Animale - Key offerings
- 12.8 Dechra Pharmaceuticals Plc
- Exhibit 142: Dechra Pharmaceuticals Plc - Overview
- Exhibit 143: Dechra Pharmaceuticals Plc - Business segments
- Exhibit 144: Dechra Pharmaceuticals Plc - Key offerings
- Exhibit 145: Dechra Pharmaceuticals Plc - Segment focus
- 12.9 Elanco Animal Health Inc.
- Exhibit 146: Elanco Animal Health Inc. - Overview
- Exhibit 147: Elanco Animal Health Inc. - Product / Service
- Exhibit 148: Elanco Animal Health Inc. - Key offerings
- 12.10 LABORATORIOS CALIER S.A
- Exhibit 149: LABORATORIOS CALIER S.A - Overview
- Exhibit 150: LABORATORIOS CALIER S.A - Product / Service
- Exhibit 151: LABORATORIOS CALIER S.A - Key offerings
- 12.11 Mars Inc.
- Exhibit 152: Mars Inc. - Overview
- Exhibit 153: Mars Inc. - Product / Service
- Exhibit 154: Mars Inc. - Key news
- Exhibit 155: Mars Inc. - Key offerings
- 12.12 Merck and Co. Inc.
- Exhibit 156: Merck and Co. Inc. - Overview
- Exhibit 157: Merck and Co. Inc. - Business segments
- Exhibit 158: Merck and Co. Inc. - Key news
- Exhibit 159: Merck and Co. Inc. - Key offerings
- Exhibit 160: Merck and Co. Inc. - Segment focus
- 12.13 Neogen Corp.
- Exhibit 161: Neogen Corp. - Overview
- Exhibit 162: Neogen Corp. - Business segments
- Exhibit 163: Neogen Corp. - Key news
- Exhibit 164: Neogen Corp. - Key offerings
- Exhibit 165: Neogen Corp. - Segment focus
- 12.14 Norbrook Laboratories Ltd.
- Exhibit 166: Norbrook Laboratories Ltd. - Overview
- Exhibit 167: Norbrook Laboratories Ltd. - Product / Service
- Exhibit 168: Norbrook Laboratories Ltd. - Key offerings
- 12.15 Vetoquinol SA
- Exhibit 169: Vetoquinol SA - Overview
- Exhibit 170: Vetoquinol SA - Business segments
- Exhibit 171: Vetoquinol SA - Key news
- Exhibit 172: Vetoquinol SA - Key offerings
- Exhibit 173: Vetoquinol SA - Segment focus
- 12.16 Virbac Group
- Exhibit 174: Virbac Group - Overview
- Exhibit 175: Virbac Group - Business segments
- Exhibit 176: Virbac Group - Key news
- Exhibit 177: Virbac Group - Key offerings
- Exhibit 178: Virbac Group - Segment focus
- 12.17 Zoetis Inc.
- Exhibit 179: Zoetis Inc. - Overview
- Exhibit 180: Zoetis Inc. - Business segments
- Exhibit 181: Zoetis Inc. - Key news
- Exhibit 182: Zoetis Inc. - Key offerings
- Exhibit 183: Zoetis Inc. - Segment focus
13 Appendix
- 13.1 Scope of the report
- 13.2 Inclusions and exclusions checklist
- Exhibit 184: Inclusions checklist
- Exhibit 185: Exclusions checklist
- 13.3 Currency conversion rates for US$
- Exhibit 186: Currency conversion rates for US$
- 13.4 Research methodology
- Exhibit 187: Research methodology
- Exhibit 188: Validation techniques employed for market sizing
- Exhibit 189: Information sources
- 13.5 List of abbreviations
- Exhibit 190: List of abbreviations
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
- Manufacturers and suppliers
- Channel partners
- Industry experts
- Strategic decision makers
Secondary sources
- Industry journals and periodicals
- Government data
- Financial reports of key industry players
- Historical data
- Press releases
DATA ANALYSIS
Data Synthesis
- Collation of data
- Estimation of key figures
- Analysis of derived insights
Data Validation
- Triangulation with data models
- Reference against proprietary databases
- Corroboration with industry experts
REPORT WRITING
Qualitative
- Market drivers
- Market challenges
- Market trends
- Five forces analysis
Quantitative
- Market size and forecast
- Market segmentation
- Geographical insights
- Competitive landscape
PURCHASE FULL REPORT OF
companion animal specialty drugs market market
Key Questions Answered
- What are the key global market and the regional market share?
- What are the revenue-generating key market segments?
- What are the key factors driving and challenging this market’s growth?
- Who are the key market vendors and their growth strategies?
- What are the latest trends influencing the growth of this market?
- What are the variables influencing the market growth in the primary regions?
- What are the factors influencing the growth of the parent market?
Why should you prefer Technavio's market insights report?
- Off-the-shelf research reports
- Reports can be tailored to meet the customer's needs
- Trusted by more than 100 fortune 500 organizations
- Information about the market's key drivers, trends, and challenges
- Parent market analysis
- Every week, 50,000 people visit our subscription platform
- Detailed vendors report with competitive landscape
- Covid-19 impact and recovery analysis
- Data on revenue-generating market segments
- Details on the market shares of various regions
- Five-force market analysis